| Registry | NCT07493720, acronym P-Beta-H |
|---|---|
| Status | Not yet recruiting |
| Study type | Observational |
| Enrollment | 40 (Estimated) |
| Sponsor | University of Nebraska (Other) |
| Conditions | Pregnancy |
| Interventions | Beta-hCG (Diagnostic test) |
| Dates | start 2026-07-01 (estimated), primary completion 2026-12-01 (estimated), completion 2026-12-01 (estimated), first posted 2026-03-25, last updated 2026-03-25 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Pregnancy All trials of Beta-hCG
The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood.
The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood. This data will help the investigator compare trending levels of beta-hCG levels in pregnant patients between venous blood vs peripheral blood which may help determine levels at which the peripheral blood may no longer be detectable on a POC pregnancy test.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Cohort 1 | Diagnostic Test: Beta-hCG | 19 years of age or older, positive pregnancy status |
Sex: Female, ages: 19 Years to any
Inclusion Criteria: 19 years of age, positive pregnant status recorded in EMR, presenting to Nebraska Medicine OB/GYN clinic - Exclusion Criteria: No meeting the inclusion criteria \-
| Facility | City | Country | Status |
|---|---|---|---|
| University of Nebraska Medical Center | Omaha, Nebraska | United States |